Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y A Joe

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Archives of Biochemistry and Biophysics|March 4, 2000
Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activityH Lee, H K Kim, J H Lee, et al.
International Journal of Cancer|July 27, 1999
Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3Y A Joe, Y K Hong, D S Chung, et al.
Experimental & Molecular Medicine|January 12, 2000
Purification and characterization of recombinant murine endostatin in E. coliW K You, S H So, H Lee, et al.
International Journal of Oncology|October 18, 2001
Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomasI A Kim, Y J Yang, S C Yoon, et al.
Journal of Korean Medical Science|July 15, 2000
Potentials and limitations of adenovirus-p53 gene therapy for brain tumorsY K Hong, Y A Joe, Y J Yang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Archives of Biochemistry and Biophysics|March 4, 2000
Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activityH Lee, H K Kim, J H Lee, et al.
International Journal of Cancer|July 27, 1999
Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3Y A Joe, Y K Hong, D S Chung, et al.
Experimental & Molecular Medicine|January 12, 2000
Purification and characterization of recombinant murine endostatin in E. coliW K You, S H So, H Lee, et al.
International Journal of Oncology|October 18, 2001
Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomasI A Kim, Y J Yang, S C Yoon, et al.
Journal of Korean Medical Science|July 15, 2000
Potentials and limitations of adenovirus-p53 gene therapy for brain tumorsY K Hong, Y A Joe, Y J Yang, et al.
Pageof 2